Reasons for Ineligibility in HIV Vaccine Trials in Kenya
Author Information
Author(s): Omosa-Manyonyi Gloria S., Jaoko Walter, Anzala Omu, Ogutu Hilda, Wakasiaka Sabina, Malogo Roselyn, Nyange Jacqueline, Njuguna Pamela, Ndinya-Achola Jeckoniah, Bhatt Kirana, Farah Bashir, Oyaro Micah, Schmidt Claudia, Priddy Frances, Fast Patricia
Primary Institution: Kenya AIDS Vaccine Initiative (KAVI), University of Nairobi, Nairobi, Kenya
Hypothesis
What are the reasons for participant ineligibility in HIV vaccine clinical trials conducted in Kenya?
Conclusion
Over 61% of the screening exclusions in clinically healthy people were due to laboratory abnormalities.
Supporting Evidence
- 281 participants were screened for two clinical trials.
- 167 participants (59.4%) met the inclusion/exclusion criteria.
- 61.4% of ineligibility was due to laboratory abnormalities.
- 30.7% of ineligibility was due to medical abnormalities.
- 18.6% of eligible participants declined enrolment.
Takeaway
When people wanted to join HIV vaccine trials, many were turned away because their lab tests showed problems. This means we need to use local lab standards to help more people join.
Methodology
Participants were screened for eligibility through medical history, physical examination, and laboratory testing.
Potential Biases
Potential bias due to reliance on non-local laboratory reference ranges for eligibility.
Limitations
The study did not include all possible endemic co-morbidities that could affect laboratory results.
Participant Demographics
Participants were aged 18 to 60, with a mix of males and females.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website